Identification of novel mitochondrial mutations in Leber's hereditary optic neuropathy.
OBJECTIVE
To screen mitochondrial DNA (mtDNA) variations in Leber hereditary optic neuropathy (LHON).


METHODS
Ten LHON patients were selected from neuro-ophthalmology clinics of All India Institute of Medical Sciences (AIIMS), New Delhi, India. Clinical evaluation included slit-lamp biomicroscopy, fundus examination, and neuroimaging. DNA was isolated from whole blood samples. The entire coding region of the mitochondrial genome was amplified by PCR in ten patients and 20 controls. The full mtDNA genome except D-loop was sequenced. All sequences were analyzed against mitochondrial reference sequence NC_012920.


RESULTS
MtDNA sequencing revealed a total of 30 nucleotide variations in the ten LHON patients and 29 in the 20 controls. Of 30 changes, 30.00% (9/30) were nonsynonymous, and the remaining 70.00% (21/30) were synonymous. In controls, a total of five changes were nonsynonymous. Out of the total 14 nonsynonymous changes observed in cases and controls, four (p.A52T in nicotinamide adenine dinucleotide [NADH] dehydrogenase [ND1] protein; p.L128Q in ND2; p.W48R in ATPase6; p.R340H in ND4 protein) were pathogenic. Four patients were positive for either of pathogenic changes. In total, 16.66% (5/30) variations were novel out of which 40.00% (2/5) were nonsynonymous. All novel variations were submitted to the GenBank database, and accession numbers were obtained. Primary LHON mutations in complex I genes have been considered a hallmark feature of LHON patients, and primary LHON mutations were present in two cases in this study. Mutations in complex I genes (ND genes) account for 50%-90% of LHON pedigrees in different ethnic pedigrees. In this study the highest numbers of changes were also present in complex I genes (46.66%; 14/30) followed by complex IV (30.00%; 9/30), complex III (16.66%; 5/30), and then complex V (6.66%; 2/30). Complex I had 5/30 (16.66%) nonsynonymous changes, complex III had 1/30 (3.33%), complex IV had 1/30 (3.33%), and complex V had 2/30 (6.66%) nonsynonymous changes. Nonsynonymous mutations in cytochrome c oxidase (COX) genes have been reported previously in LHON patients. Nonsynonymous mtDNA variations may adversely affect the respiratory chain and impair the oxidative phosphorylation (OXPHOS) pathway, resulting in low ATP production and elevated reactive oxygen species (ROS) levels, which cause oxidative stress. It has previously been reported that oxidative stress (OS) leads to oxidative damage of cellular macromolecules, such as mitochondrial and nuclear DNA, proteins, and lipids along with energy depletion and a local imbalance of calcium homeostasis, resulting in neuronal degeneration. OS is the underlying etiology in several ocular diseases and also plays an essential role in LHON.


CONCLUSIONS
A total of five novel mtDNA variations were identified in this study. Nonsynonymous mtDNA variations may adversely affect the respiratory chain and impair the OXPHOS pathway, resulting in low ATP production and elevated ROS levels. OS further damages both nuclear and mtDNA. This preliminary study describes mtDNA sequence variations in a relatively small number of LHON patients of north Indian ethnic origin. However, these results should be confirmed in other populations. Early diagnosis of mtDNA variations and prompt anti-oxidant administration in these cases may delay OS-induced injury to retinal ganglion cells (RGCs) and hence improve visual prognosis.
Kumar
Manoj
M
Laboratory for Molecular Reproduction and Genetics, Department of Anatomy, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, India.
Tanwar
Mukesh
M
Saxena
Rohit
R
Sharma
Pradeep
P
Dada
Rima
R
D000328:Adult; D004272:DNA, Mitochondrial / Q000235:genetics*; D005820:Genetic Testing; D006801:Humans; D008297:Male; D009154:Mutation; D029242:Optic Atrophy, Hereditary, Leber / Q000235:genetics*; D010641:Phenotype; D011110:Polymorphism, Genetic; D055815:Young Adult
D004272:DNA, Mitochondrial
Srp Arh Celok Lek. 2003 Mar-Apr;131(3-4):137-42
14608877
Graefes Arch Clin Exp Ophthalmol. 2001 Jul;239(6):437-40
11561792
Nucleic Acids Res. 2003 Jul 1;31(13):3812-4
12824425
Arch Biochem Biophys. 1985 Mar;237(2):408-14
2983613
Proc Natl Acad Sci U S A. 1994 Jun 21;91(13):6206-10
8016139
Am J Hum Genet. 2003 Jun;72(6):1460-9
12736867
Annu Rev Biochem. 1992;61:1175-212
1497308
Invest Ophthalmol Vis Sci. 2006 Oct;47(10):4211-20
17003408
Nat Med. 1997 Feb;3(2):124-5
9018221
Invest Ophthalmol Vis Sci. 2006 Jun;47(6):2533-41
16723467
Mol Vis. 2007 Aug 29;13:1516-28
17893651
Mitochondrion. 2007 Feb-Apr;7(1-2):140-6
17300996
Biochem Biophys Res Commun. 1992 Sep 30;187(3):1551-7
1417830
Eye (Lond). 2001 Apr;15(Pt 2):183-8
11339587
Am J Hum Genet. 2003 Feb;72(2):333-9
12518276
Clin Neuropathol. 2008 Nov-Dec;27(6):414-23
19130740
Hum Mol Genet. 2001 Mar 15;10(6):591-7
11230178
Clin Genet. 1996 Dec;50(6):535-7
9147893
Mol Cell Biol. 1996 Mar;16(3):771-7
8622678
Mol Vis. 2010 Mar 24;16:518-33
20361014
J Genet Genomics. 2008 Nov;35(11):649-55
19022198
Brain. 2001 Jan;124(Pt 1):209-18
11133798
Mitochondrion. 2008 Jun;8(3):205-10
18440284
Nucleic Acids Res. 2002 Sep 1;30(17):3894-900
12202775
Hum Mutat. 1995;6(4):311-25
8680405
Prog Retin Eye Res. 2006 Jul;25(4):381-96
16829155
Ann Neurol. 2004 Nov;56(5):631-41
15505787
Br J Ophthalmol. 2004 Feb;88(2):286-90
14736793
Am J Ophthalmol. 2000 Dec;130(6):803-12
11124301
Invest Ophthalmol Vis Sci. 2005 Sep;46(9):3177-87
16123417
Biochem J. 1980 Nov 1;191(2):421-7
6263247
Ann Neurol. 2002 Jun;51(6):774-8
12112086
Mol Aspects Med. 1997;18 Suppl:S263-7
9266534
Arch Gynecol Obstet. 2010 Sep;282(3):313-8
20361200
Mol Vis. 2008 Jan 10;14:29-36
18246027
Biochim Biophys Acta. 2010 Jan;1802(1):100-10
19682572
Biochem Biophys Res Commun. 2002 Jul 12;295(2):342-7
12150954
Biochem Biophys Res Commun. 2009 Nov 20;389(3):466-72
19732751
Aust N Z J Ophthalmol. 1992 Aug;20(3):177-84
1449769
Ann Neurol. 2002 Nov;52(5):534-42
12402249
Eur J Biochem. 1996 Jul 1;239(1):201-7
8706709
Acta Neuropathol. 2006 Jun;111(6):610-6
16525806
Ophthalmic Genet. 2002 Sep;23(3):191-7
12324878
Neurogenetics. 2010 Jul;11(3):349-56
20232220
Am J Hum Genet. 1995 May;56(5):1238-40
7726182
Invest Ophthalmol Vis Sci. 2004 Nov;45(11):4049-59
15505055
Arch Ophthalmol. 1993 Nov;111(11):1486-90
8240102
Eye (Lond). 1999 Apr;13 ( Pt 2):183-8
10450379
Trends Genet. 1997 Nov;13(11):450-5
9385842
Prog Retin Eye Res. 2004 Jan;23(1):53-89
14766317
Nucleic Acids Res. 2005 Jan 1;33(Database issue):D611-3
15608272
J Hum Genet. 2006;51(10):851-856
16972023
Lancet. 1992 Jun 6;339(8806):1427-8
1350847
Biochemistry. 1998 Aug 25;37(34):11792-6
9718301
Science. 1988 Dec 9;242(4884):1427-30
3201231
Int J Biochem Cell Biol. 2005 Apr;37(4):822-34
15694841
Biochim Biophys Acta. 2009 May;1793(5):817-24
19269308
Am J Hum Genet. 2007 Aug;81(2):228-33
17668373
Invest Ophthalmol Vis Sci. 2007 Dec;48(12):5591-6
18055808
J Med Genet. 2002 Mar;39(3):162-9
11897814